Regenerative biomaterials acquired by NexGel — Healthcare M&A

NexGel has signed a definitive agreement to license and acquire NexGel acquisitions of a portfolio of commercial-stage regenerative biomaterial products, a medical devices business in the healthcare sector. The target portfolio includes regenerative biomaterial offerings designed for medical devices applications, supporting NexGel’s expansion in advanced healthcare M&A. NexGel acquisitions focus on add on acquisition of commercial-stage products to broaden product revenue and strengthen its medical devices pipeline. The deal is structured as an add on acquisition within healthcare M&A, combining licensing and acquisition terms, with details on purchase price and expected close date not provided.